P
PharmaCann
largest vertically-integrated and unified medical cannabis company
About PharmaCann
PharmaCann is a prominent player in the cannabis industry, dedicated to improving people's lives through the cultivation, production, and distribution of high-quality cannabis products. Founded in 2014, PharmaCann has quickly grown to become one of the largest vertically integrated cannabis companies in the United States. This means they control every step of the process—from growing the cannabis plants to processing them into various products and finally selling them in their own dispensaries. This vertical integration allows PharmaCann to maintain high standards of quality and safety across all their products.
The company operates in a rapidly expanding market, focusing on both medical and adult-use cannabis. They are licensed to operate in eight states, including Illinois, Maryland, Massachusetts, New York, Ohio, and Pennsylvania. Their product offerings include a range of cannabis-related items such as flower, edibles, tinctures, and topicals, all designed to meet the diverse needs of their clients.
PharmaCann serves a broad spectrum of clients, from medical patients seeking relief from various conditions to adult consumers looking for wellness and recreational products. The company’s mission is to provide safe, reliable, and top-quality cannabis products that are both effective and affordable. By investing in their employees, state-of-the-art facilities, and rigorous research and development, PharmaCann aims to lead the industry in innovation and quality.
The business model of PharmaCann revolves around vertical integration, which helps them control costs and ensure product quality. They make money by selling their products directly to consumers through their network of dispensaries, as well as through wholesale channels to other retailers. Their commitment to truth and transparency, along with their focus on sustainable practices, positions them as a trusted name in the cannabis industry.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Oak Park, United States
- Employees
- 671
- Open positions
- 41
- Dealroom signal
- 74.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Apr 2024 | $74M | — | Undisclosed | ↗ |
| GROWTH EQUITY VCOther financing | Apr 2024 | $18M | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for PharmaCann is 11K monthly website visits, up 17% over the last three months. PharmaCann's team grew 38.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
MedMen
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about PharmaCann on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PharmaCann’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







